AnodynePyridoxine
| Pyridoxine | |
|---|---|
 |
| Salts [] | |
|---|---|
| Pyridoxine hydrochloride | |
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 169.18 g/mol [1] |
| Melting point | 159-162 °C [1] |
| Solubility | 79 mg/mL [1] |
| Predicted LogP | -0.8 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C8H11NO3 [1] |
| IUPAC name | 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol [1] |
| SMILES | CC1=NC=C(C(=C1O)CO)CO [1] |
| InChI | InChI=1S/C8H11NO3/c1-5-8(12)7(4-11)6(3-10)2-9-5/h2,10-12H,3-4H2,1H3 [1] |
| InChIKey | LXNHXLLTXMVWPM-UHFFFAOYSA-N [1] |
| Pharmacokinetics[] | |
|---|---|
| Elimination half-life | several weeks (see #Metabolism for details) |
Pyridoxine (also known as Pyridoxine, 65-23-6, Pyridoxol, Pyridoxin, Adermine, Gravidox, 3-hydroxy-4,5-bis(hydroxymethyl)-2-methylpyridine, Hydoxin, Pyridoxolum or 3,4-Pyridinedimethanol, 5-hydroxy-6-methyl-) is a
Chemistry
Salts []
Pyridoxine is typically found in the form of its hydrochloride salt.
Stereochemistry []
Pyridoxine is a achiral mixture
Pharmacology
ATC Classification
Metabolism
Subjective effects []
| Usernotes [] | |
|---|---|
| 0xea / Pyridoxine via Oral, Intravenousat 50-90mg oral and 40mg intravenous |
|
Legal status []
- United Kingdom: Pyridoxine is a P substance.[3]
- United States: Pyridoxine is a OTC substance.
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 1054, Pyridoxine. Accessed January 6, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/1054
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Pyridoxine. UNII: KV2JZ1BI6Z. Global Substance Registration System. Accessed January 6, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/KV2JZ1BI6Z
Pyridoxine 50mg Tablets - Summary of Product Characteristics (SmPC). April 27, 2015. Accessed January 6, 2026. https://www.medicines.org.uk/emc/medicine/28135/SPC/Pyridoxine+50mg+Tablets/